AU2001269531A1 - Sulfone derivatives, process for their production and use thereof - Google Patents

Sulfone derivatives, process for their production and use thereof

Info

Publication number
AU2001269531A1
AU2001269531A1 AU2001269531A AU6953101A AU2001269531A1 AU 2001269531 A1 AU2001269531 A1 AU 2001269531A1 AU 2001269531 A AU2001269531 A AU 2001269531A AU 6953101 A AU6953101 A AU 6953101A AU 2001269531 A1 AU2001269531 A1 AU 2001269531A1
Authority
AU
Australia
Prior art keywords
production
sulfone derivatives
sulfone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269531A
Inventor
Masaki Kawamura
Keiji Kubo
Toshio Miyawaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001269531A1 publication Critical patent/AU2001269531A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2001269531A 2000-07-17 2001-07-17 Sulfone derivatives, process for their production and use thereof Abandoned AU2001269531A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000221065 2000-07-17
JP2000-221065 2000-07-17
PCT/JP2001/006148 WO2002006234A1 (en) 2000-07-17 2001-07-17 Sulfone derivatives, process for their production and use thereof

Publications (1)

Publication Number Publication Date
AU2001269531A1 true AU2001269531A1 (en) 2002-01-30

Family

ID=18715557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269531A Abandoned AU2001269531A1 (en) 2000-07-17 2001-07-17 Sulfone derivatives, process for their production and use thereof

Country Status (5)

Country Link
US (1) US20030187023A1 (en)
EP (1) EP1302462A4 (en)
AU (1) AU2001269531A1 (en)
CA (1) CA2416384A1 (en)
WO (1) WO2002006234A1 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074762A1 (en) * 2001-03-15 2002-09-26 Takeda Chemical Industries, Ltd. Process for producing sulfone derivative
US6875893B2 (en) * 2002-05-23 2005-04-05 Cephalon, Inc. Preparations of a sulfinyl acetamide
US7262194B2 (en) * 2002-07-26 2007-08-28 Euro-Celtique S.A. Therapeutic agents useful for treating pain
WO2004035579A1 (en) * 2002-10-15 2004-04-29 Takeda Pharmaceutical Company Limited Imidazopyridine derivative, process for producing the same, and use
EP1564213A4 (en) * 2002-11-22 2009-05-27 Takeda Pharmaceutical Imidazole derivative, process for producing the same, and use
GB0302431D0 (en) * 2003-01-30 2003-03-05 Glaxo Group Ltd Novel compounds
EP2364982A1 (en) * 2003-04-18 2011-09-14 ONO Pharmaceutical Co., Ltd. Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof
WO2005030740A1 (en) * 2003-09-30 2005-04-07 Takeda Pharmaceutical Company Limited Thiazoline derivative and use of the same
US7820673B2 (en) 2003-12-17 2010-10-26 Takeda Pharmaceutical Company Limited Urea derivative, process for producing the same, and use
PT1701940E (en) * 2003-12-23 2008-07-30 Lundbeck & Co As H 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri
TWI396686B (en) * 2004-05-21 2013-05-21 Takeda Pharmaceutical Cyclic amide derivative, and its production and use
AR052308A1 (en) * 2004-07-16 2007-03-14 Lundbeck & Co As H DERIVATIVES OF 2- (1H-INDOLILSULFANIL) -ARILAMINE AND A PHARMACEUTICAL COMPOSITION CONTAINING THE COMPOUND
JP5135795B2 (en) * 2004-08-27 2013-02-06 小野薬品工業株式会社 COMPOUND CONTAINING BASIC GROUP AND USE THEREOF
US20060111347A1 (en) * 2004-10-06 2006-05-25 Amgen Inc. Substituted sulfones and methods of use
US7432391B2 (en) 2005-05-24 2008-10-07 Daito Chemix Corporation Process for the production of tert-butyl N-(2-bromoethyl)carbamate
US7629473B2 (en) * 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (en) * 2005-06-17 2007-06-20 Lundbeck & Co As H DERIVATIVES OF BENZO (B) FURANO AND BENZO (B) THIOPHEN, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TREATMENT OF DISEASES MEDIATED BY THE INHIBITION OF THE REINFORCEMENT OF AMINA BOSS NEUTRANTS.
EP1961744B1 (en) * 2005-11-18 2013-04-17 Ono Pharmaceutical Co., Ltd. Basic group-containing compound and use thereof
WO2007132846A1 (en) * 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
AR073380A1 (en) 2008-09-25 2010-11-03 Takeda Pharmaceutical SOLID PHARMACEUTICAL COMPOSITION. MULTI-PAD TABLET
WO2010050445A1 (en) 2008-10-27 2010-05-06 武田薬品工業株式会社 Bicyclic compound
EP2371826A4 (en) 2008-12-29 2012-06-27 Takeda Pharmaceutical Novel fused ring compound and use thereof
TW201033213A (en) 2009-01-27 2010-09-16 Takeda Pharmaceutical Fused ring compound and use thereof
CA2760073A1 (en) 2009-04-30 2010-11-04 Takeda Pharmaceutical Company Limited Solid preparation
EP2440541A1 (en) 2009-06-09 2012-04-18 Takeda Pharmaceutical Company Limited Novel fused cyclic compound and use thereof
KR20120039046A (en) 2009-07-28 2012-04-24 다케다 야쿠힌 고교 가부시키가이샤 Tablet
KR20130094211A (en) 2010-04-27 2013-08-23 다케다 야쿠힌 고교 가부시키가이샤 Bicyclic compound derivatives and their use as acc inhibitors
ES2524896T3 (en) 2010-06-16 2014-12-15 Takeda Pharmaceutical Company Limited Amide Compound Crystal
CA2806258A1 (en) 2010-07-23 2012-01-26 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and application thereof
JP5816626B2 (en) 2010-09-17 2015-11-18 武田薬品工業株式会社 Diabetes treatment
TW201242951A (en) 2010-11-30 2012-11-01 Takeda Pharmaceutical Bicyclic compound
CA2827271A1 (en) 2011-02-17 2012-08-23 Takeda Pharmaceutical Company Limited Production method of optically active dihydrobenzofuran derivative
US9133129B2 (en) 2011-10-24 2015-09-15 Takeda Pharmaceutical Company Limited Bicyclic compound
EP2802571A1 (en) 2012-01-12 2014-11-19 Takeda Pharmaceutical Company Limited Benzimidazole derivatives as mch receptor antagonists
WO2013122029A1 (en) 2012-02-13 2013-08-22 武田薬品工業株式会社 Aromatic ring compound
US9382188B2 (en) 2012-02-13 2016-07-05 Takeda Pharmaceutical Company Limited Aromatic ring compound
JP6077555B2 (en) 2012-02-15 2017-02-08 武田薬品工業株式会社 tablet
WO2013125732A1 (en) 2012-02-24 2013-08-29 Takeda Pharmaceutical Company Limited Aromatic ring compound
CN104350040B (en) 2012-03-29 2016-06-01 武田药品工业株式会社 Aromatic compound
US9440987B2 (en) 2012-05-10 2016-09-13 Takeda Pharmaceutical Company Limited Aromatic ring compound
US9505772B2 (en) 2012-05-10 2016-11-29 Takeda Pharmaceutical Company Limited Aromatic ring compound
JP2015520752A (en) 2012-05-11 2015-07-23 アッヴィ・インコーポレイテッド Pyridazine and pyridine derivatives as NAMPT inhibitors
AR092843A1 (en) 2012-06-05 2015-05-06 Takeda Pharmaceuticals Co SOLID PREPARATION
JP2015127299A (en) 2012-07-19 2015-07-09 武田薬品工業株式会社 Solid preparation
JPWO2014030743A1 (en) 2012-08-24 2016-08-08 武田薬品工業株式会社 Heterocyclic compounds
ES2629729T3 (en) 2013-03-14 2017-08-14 Takeda Pharmaceutical Company Limited Spiro azetidine asoxazol derivatives and their use as sstr5 antagonists
US10005720B2 (en) 2013-04-05 2018-06-26 North Carolina Central University Compounds useful for the treatment of metabolic disorders and synthesis of the same
UY35650A (en) 2013-07-09 2015-02-27 Takeda Pharmaceutical HETEROCYCLIC COMPOUND
EP3031799B1 (en) 2013-08-09 2018-04-04 Takeda Pharmaceutical Company Limited Aromatic compound
JO3442B1 (en) 2013-10-07 2019-10-20 Takeda Pharmaceuticals Co Antagonists of somatostatin receptor subtype 5 (sstr5)
US9428470B2 (en) 2014-02-13 2016-08-30 Takeda Pharmaceutical Company Limited Heterocyclic compound
US9346776B2 (en) 2014-02-13 2016-05-24 Takeda Pharmaceutical Company Limited Fused heterocyclic compound
AR111199A1 (en) 2017-03-31 2019-06-12 Takeda Pharmaceuticals Co GPR40 AGONIST AROMATIC COMPOUND
US11186565B2 (en) 2017-03-31 2021-11-30 Takeda Pharmaceutical Company Limited Aromatic compound
JOP20180028A1 (en) 2017-03-31 2019-01-30 Takeda Pharmaceuticals Co Peptide compound
CN112236161A (en) 2018-03-23 2021-01-15 卡莫特治疗学股份有限公司 Modulators of G protein-coupled receptors
AR116019A1 (en) 2018-08-27 2021-03-25 Scohia Pharma Inc GUANIDINOBENZOYL DERIVATIVES AS ENTEROPEPTIDASE INHIBITORS
US20220135638A1 (en) 2018-09-24 2022-05-05 Takeda Pharmaceutical Company Limited Gip receptor agonist peptide compounds and uses thereof
WO2020067575A1 (en) 2018-09-24 2020-04-02 Takeda Pharmaceutical Company Limited Gip receptor agonist peptide compounds and uses thereof
CA3173129A1 (en) 2020-03-25 2021-09-30 Antoine Charles Olivier HENNINOT Qd dosing of gip receptor agonist peptide compounds and uses thereof
US20230143604A1 (en) 2020-03-25 2023-05-11 Takeda Pharmaceutical Company Limited Qw dosing of gip receptor agonist peptide compounds and uses thereof
US20230151074A1 (en) 2021-05-13 2023-05-18 Carmot Therapeutics, Inc. Modulators of g-protein coupled receptors
WO2023169456A1 (en) 2022-03-09 2023-09-14 Gasherbrum Bio , Inc. Heterocyclic glp-1 agonists
WO2023179542A1 (en) 2022-03-21 2023-09-28 Gasherbrum Bio , Inc. 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
WO2023198140A1 (en) 2022-04-14 2023-10-19 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210152A (en) * 1978-05-01 1980-07-01 International Medical Electronics Ltd. Method and apparatus for measuring and controlling the output power of a shortwave therapy apparatus
US5097844A (en) * 1980-04-02 1992-03-24 Bsd Medical Corporation Hyperthermia apparatus having three-dimensional focusing
US4798215A (en) * 1984-03-15 1989-01-17 Bsd Medical Corporation Hyperthermia apparatus
US5038780A (en) * 1988-04-29 1991-08-13 The Biotronics Research Corp. Method and apparatus for capacitively regenerating tissue and bone
TW394760B (en) * 1993-09-07 2000-06-21 Hoffmann La Roche Novel Carboxamides, process for their preparation and pharmaceutical composition containing the same
IL115420A0 (en) * 1994-09-26 1995-12-31 Zeneca Ltd Aminoheterocyclic derivatives
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
GB9602294D0 (en) * 1996-02-05 1996-04-03 Zeneca Ltd Heterocyclic compounds
DE69835430T2 (en) * 1997-05-30 2007-03-08 Takeda Pharmaceutical Co. Ltd. Sulphonamide derivatives, their preparation and their use
GB9715895D0 (en) * 1997-07-29 1997-10-01 Zeneca Ltd Heterocyclic compounds
AU1692399A (en) * 1997-12-26 1999-07-19 Mochida Pharmaceutical Co., Ltd. Aromatic compounds having cyclic amino or salts thereof
AU2298899A (en) * 1998-02-05 1999-08-23 Takeda Chemical Industries Ltd. Sulfonamide derivatives, process for producing the same and utilization thereof
PL343424A1 (en) * 1998-04-10 2001-08-13 Japan Tobacco Inc Amidine compounds
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
ATE325114T1 (en) * 1999-06-22 2006-06-15 Takeda Pharmaceutical ACYLHYDRAZINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND THEIR USE
AU774397B2 (en) * 1999-06-30 2004-06-24 Mochida Pharmaceutical Co., Ltd. Tricyclic compounds having spiro union
US6511973B2 (en) * 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
DE10155075A1 (en) * 2001-11-09 2003-05-22 Merck Patent Gmbh Cyclic sulfonamides
TW200307667A (en) * 2002-05-06 2003-12-16 Bristol Myers Squibb Co Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
DE10229070A1 (en) * 2002-06-28 2004-01-15 Merck Patent Gmbh Phenyl derivatives 5
JP2004101769A (en) * 2002-09-06 2004-04-02 Sharp Corp Image adjusting method and image forming apparatus
AU2003279735A1 (en) * 2002-10-02 2004-04-23 Bristol-Myers Squibb Company Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors
TWI396686B (en) * 2004-05-21 2013-05-21 Takeda Pharmaceutical Cyclic amide derivative, and its production and use

Also Published As

Publication number Publication date
CA2416384A1 (en) 2003-01-16
EP1302462A4 (en) 2007-07-18
WO2002006234A1 (en) 2002-01-24
US20030187023A1 (en) 2003-10-02
EP1302462A1 (en) 2003-04-16

Similar Documents

Publication Publication Date Title
AU2001269531A1 (en) Sulfone derivatives, process for their production and use thereof
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
HUP0202472A3 (en) Sulfonyl carboxiamide derivatives, method for their production and their use as medicaments
AU1271201A (en) Azepinoindole derivatives, the production and use thereof
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
AU2002210548A1 (en) Sulphur-containing indirubin derivatives, production and use thereof
AU2000254308A1 (en) Pyrazolopyrimidinone derivatives, process for their preparation and their use
AU2001262229A1 (en) Cyclipostins, a method for their production and the use of the same
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2002227952A1 (en) Klainetin and derivatives thereof, method for their production and the use of the same
HK1061655A1 (en) Caloporoside derivatives, methods for the production thereof and their use
AU2003235121A1 (en) Novel thiol derivative, process for producing the same and use thereof
AU2002333449A1 (en) C2-substituted indane-1-ols and their derivatives, method for their production and their use as medicaments
AU6730001A (en) Component, method for production and use thereof
AU2002352606A1 (en) Eurotinone and derivatives thereof, method for the production and use of the same
AU2795202A (en) Klainetin and derivatives thereof, method for their production and the use of the same
AU7517800A (en) 3-vinylpyrrole derivatives, method for the production thereof and their use as medicaments
AU2002336085A1 (en) C2-substituted Indane-1-ones and their derivatives, method for their production and their use as medicaments
AU2002339519A1 (en) Coniosulphides and their derivatives, method for their production and use as medicaments
AU2002336983A1 (en) C2-disubstituted Indane-1-ones and their derivatives, method for their production and their use as medicaments
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
AU2001277720A1 (en) (thio)urea derivatives, process for their production and medicines containing the derivatives